S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Protocall Services Names Dr. Ben Locke as Chief Clinical Officer

Behavioral health veteran Dr. Ben Locke has been appointed Chief Clinical Officer at Portland-based Protocall Services. He steps into the role following a successful tenure at Togetherall, aiming to scale the firm’s crisis intervention and digital mental health operations across higher education and national community health networks.

Protocall Services Names Dr. Ben Locke as Chief Clinical Officer
Photo: Bio & News

Dr. Locke brings two decades of clinical experience to the position, including a long-standing tenure at Penn State University. During his time there, he co-founded the Center for Collegiate Mental Health, an influential research network that tracks mental health trends across nearly 900 institutions. At Protocall, he will manage clinical strategy and quality assurance, focusing on integrating evidence-based practices into the company’s expanding digital ecosystem.

He succeeds Brad Pendergraft, a founding member of the firm who served two stints at the organization spanning nearly 20 years. Pendergraft, who previously pioneered the company’s early clinical frameworks and AI-driven counselor training, will remain with the organization as a clinical consultant, focusing on the development of AI tools for behavioral health. CEO Phil Evans noted that the transition aligns with the company's broader mission to merge large-scale crisis response with specialized mental health technology.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!